Ayman Samkari
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 10%
- Molecular Biology
- Surgery
- Co-authors
- Silvia NovelloMargarita MajemDelvys Rodríguez‐AbreuSteven M. KellerEdward B. GaronJamie E. ChaftRoy S. HerbstE. Eigendorff
- Topics
- Cancer Immunotherapy and Biomarkers (41 papers)Lung Cancer Treatments and Mutations (28 papers)Lung Cancer Diagnosis and Treatment (25 papers)
- Partner nations
- United StatesSpainSouth Korea
In The Last Decade
Ayman Samkari
56 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 220
- Molecular Biology 218
- Surgery 163
Countries citing papers authored by Ayman Samkari
This map shows the geographic impact of Ayman Samkari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Samkari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Samkari more than expected).
Fields of papers citing papers by Ayman Samkari
This network shows the impact of papers produced by Ayman Samkari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Samkari. The network helps show where Ayman Samkari may publish in the future.
Co-authorship network of co-authors of Ayman Samkari
This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Samkari. A scholar is included among the top collaborators of Ayman Samkari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Samkari. Ayman Samkari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 6 | |
| 13 | 2 | |
| 14 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Studybreakdown → | 165 |
| 15 | 18 | |
| 16 | 10 | |
| 17 | 4 | |
| 18 | 1 | |
| 19 | 17 | |
| 20 | 3 |
About Ayman Samkari
Ayman Samkari is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (41 papers), Lung Cancer Treatments and Mutations (28 papers) and Lung Cancer Diagnosis and Treatment (25 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (220 citations). Ayman Samkari has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include Silvia Novello, Margarita Majem, Delvys Rodríguez‐Abreu, Steven M. Keller, Edward B. Garon, Jamie E. Chaft, Roy S. Herbst, E. Eigendorff, Moïshe Liberman and Olivier Bylicki. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.